According to our knowledge, this is the first study trying to evaluate the prognostic role of elaborate molecular clusters encompassing cyclin D1, cyclin E1, p21 (CDKN1A), p27 (CDKN1B) and p53 in the context of various breast cancer subtypes. This evidence concerns the gene CDKN1A and breast carcinoma.